"TNFRSF19" Related Products

Expand
Expand
Expand

Recombinant Human TNFRSF19, Fc Chimera

Cat.No.: TNFRSF19-282H
Product Overview: Recombinant Human TNFRSF19 (Accession # AAF71828) was produced in Mouse myeloma cell line, NS0-derived.
Source: NSO cells
Species: Human
Tag: Fc Chimera
Predicted N Terminal: Glu30
Form: Lyophilized from a 0.2 µm filtered solution in PBS.
Bio-activity: Measured by its binding ability in a functional ELISA.When Recombinant Human Lgr5/GPR49 Fc Chimera is coated at 0.5 µg/mL, Recombinant Human TROY/TNFRSF19 Fc Chimera binds with an apparent Kd <500 nM.
Molecular Mass: Recombinant Human TNFRSF19, Fc Chimera has a calculated MW of 42 kDa (monomer). In SDS-PAGE migrates as 50-55 kDa, reducing conditions.
Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
Gene Name: TNFRSF19 tumor necrosis factor receptor superfamily, member 19 [ Homo sapiens ]
Official Symbol: TNFRSF19
Synonyms: TNFRSF19; tumor necrosis factor receptor superfamily, member 19; tumor necrosis factor receptor superfamily member 19; TAJ; TAJ alpha; toxicity and JNK inducer; TRADE; TROY; TAJ-alpha;
Gene ID: 55504
mRNA Refseq: NM_001204458
Protein Refseq: NP_001191387
MIM: 606122
UniProt ID: Q9NS68
Chromosome Location: 13q12.11-q12.3

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.